Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.94 USD | -1.85% |
|
-3.76% | -11.68% |
07-01 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000 Growth Index | CI |
07-01 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000E Growth Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.68% | 604M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.76% | 25.93B | |
-24.33% | 19.27B | |
-19.40% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- TVTX Stock
- News Travere Therapeutics, Inc.
- Transcript : Retrophin, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-11-2018 09